MERRIMACK PHARMACEUTICALS IN (MACK) Stock Balance Sheet
NASDAQ:MACK • US5903282094
Current stock price
15.13 USD
0 (0%)
At close:
15.16 USD
+0.03 (+0.2%)
After Hours:
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 234.16M | 5.99M | 19.40M | 14.20M | 14.00M | |||
| Marketable Securities | 9.95M | 12.89M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 209.00K | 309.00K | 400.00K | 500.00K | 2.50M | |||
| Total Current Assets | 244.32M | 19.18M | 19.80M | 14.70M | 16.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.00K | 4.00K | 0.00 | 100.00K | 200.00K | |||
| Total Non-Current Assets | 3.00K | 4.00K | 0.00 | 0.00 | 300.00K | |||
| TOTAL ASSETS | 244.32M | 19.19M | 19.80M | 14.70M | 16.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 398.00K | 367.00K | 400.00K | 400.00K | 600.00K | |||
| Accounts Payable | 168.00K | 74.00K | 200.00K | 100.00K | 100.00K | |||
| Other Current Liabilities | 22.11M | N/A | N/A | N/A | 0.00 | |||
| Total Current Liabilities | 22.67M | 441.00K | 600.00K | 600.00K | 800.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 22.67M | 441.00K | 600.00K | 600.00K | 800.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -347.45M | -548.82M | -547.60M | -546.10M | -543.60M | |||
| Additional Paid In Capital | 567.75M | 566.22M | 565.50M | 558.90M | 558.30M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 1.34M | 1.34M | 1.30M | 1.30M | 1.30M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | 0.00 | |||
| Shares Outstanding | 14.53M | 14.35M | 14.20M | 13.40M | 13.40M | |||
| Tangible Book Value per Share | 15.25 | 1.31 | 1.35 | 1.06 | 1.19 | |||
| Total Shareholders' Equity | 221.65M | 18.75M | 19.20M | 14.20M | 16.00M | |||
| TOTAL LIABILITIES AND EQUITY | 244.32M | 19.19M | 19.80M | 14.70M | 16.80M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 10.78 | 43.50 | 33.00 | 24.50 | 20.63 | |||
| Return On Assets (ROA) | 82.05% | -6.15% | -7.58% | -17.01% | -17.86% | |||
| Return On Equity (ROE) | 90.44% | -6.30% | -7.81% | -17.61% | -18.75% | |||
All data in USD , ROIC based on taxRate of 0.21